Mojgan Rastegar
University of Manitoba
H-index: 38
North America-Canada
Top articles of Mojgan Rastegar
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Epigenetic control of adaptive or homeostatic splicing during interval-training activities | bioRxiv | Ling Liu Hai Nguyen Urmi Das Samuel Ogunsola Jiankun Yu | 2024 |
Metformin Induces MeCP2 in the Hippocampus of Male Mice with Sex-Specific and Brain-Region-Dependent Molecular Impact | Biomolecules | Khatereh Saei Arezoumand Chris-Tiann Roberts Mojgan Rastegar | 2024/4/21 |
Transcriptional Inhibition of the Mecp2 Promoter by MeCP2E1 and MeCP2E2 Isoforms Suggests Negative Auto-Regulatory Feedback that can be Moderated by … | Journal of Molecular Neuroscience | Sandhini Lockman Matthew Genung Kimia Sheikholeslami Annan Ali Sher Daniel Kroft | 2024/1/26 |
New insights into the molecular mechanisms of autistic spectrum disorders | Mojgan Rastegar | 2024/1/22 | |
Epigenetic Control and Cerebellar Neurodevelopmental Disorders | Mojgan Rastegar | 2023/2/25 | |
The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action | Yen My Vuu Ashraf Kadar Shahib Mojgan Rastegar | 2023/6/22 | |
Mitogen-and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states | Hedieh Sattarifard Akram Safaei Enzhe Khazeeva Mojgan Rastegar James R Davie | 2023/2/22 | |
Insights in epigenomics and epigenetics: 2022 | Frontiers in Genetics | Douglas M Ruden Mojgan Rastegar | 2023/6/13 |
MeCP2 is an epigenetic factor that links DNA methylation with brain metabolism | Yen My Vuu Chris-Tiann Roberts Mojgan Rastegar | 2023/2/20 | |
The epigenetic reader methyl-CpG-binding protein 2 (MeCP2) is an emerging oncogene in cancer biology | Kazem Nejati-Koshki Chris-Tiann Roberts Ghader Babaei Mojgan Rastegar | 2023/5/9 | |
rsc. li/methods | Dylan O'Flynn Jenny Lawler Azeez Yusuf Anne Parle-McDermott Denise Harold | 2003 | |
10 years of Frontiers in genetics: past discoveries, current challenges and future perspectives | Frontiers in Genetics | William C Cho Jordi Pérez-Tur Rosalba Giugno Mehdi Pirooznia Kathleen Boris-Lawrie | 2023/5/5 |
Tri-part NanoLuc as a new split technology with potential applications in chemical biology: a mini-review | Mina Oliayi Rahman Emamzadeh Mojgan Rastegar Mahboobeh Nazari | 2023 | |
Synthesis and characterization of N‐rich fluorescent bio‐dots as a reporter in the design of dual‐labeled FRET probe for TaqMan PCR: A feasibility study | Biotechnology and Applied Biochemistry | Mahsa Imani Nasrin Mohajeri Mojgan Rastegar Nosratollah Zarghami | 2023/4 |
MeCP2 is the protector of epigenome integrity, membrane-less nuclear architecture, and stability of chromatin assembly | Mojgan Rastegar James R Davie | 2023/10/1 | |
The Chromatin Structure at the MECP2 Gene and In Silico Prediction of Potential Coding and Non-Coding MECP2 Splice Variants | International Journal of Molecular Sciences | Danilo Shevkoplyas Yen My Vuu James R Davie Mojgan Rastegar | 2022/12/9 |
MeCP2 and transcriptional control of eukaryotic gene expression | European Journal of Cell Biology | Ghanan Bin Akhtar Marjorie Buist Mojgan Rastegar | 2022/6/1 |
Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to MECP2 Gain- and Loss-of-Function Involves MeCP2 Isoform-Specific Homeostasis in … | Cells | Marjorie Buist Nada El Tobgy Danilo Shevkoplyas Matthew Genung Annan Ali Sher | 2022/4/24 |
Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance | Journal of Drug Delivery Science and Technology | AmirAhmad Arabzadeh Kazem Nejati Mojgan Rastegar Farzaneh Fathi Mehdi Dadashpour | 2022 |
epigenetic mechanisms and their involvement in rare diseases | Frontiers in Genetics | Mojgan Rastegar Dag H Yasui | 2021/9/1 |
Co-Authors
